Iroko Pharmaceuticals Overview
- Year Founded
-
2007
- Status
-
Out of Business
- Employees
-
290
- Latest Deal Type
-
Out of Business
Iroko Pharmaceuticals General Information
Description
Developer of pharmaceutical products designed to provide responsible pain management services to patients. The company's products use proprietary technology to develop new drug products based on existing NSAIDs to relieve pain at low doses, enabling patients to lead a healthy and improved life.
Contact Information
Corporate Office
- 150 Rouse Boulevard
- Philadelphia, PA 19112
- United States
Corporate Office
- 150 Rouse Boulevard
- Philadelphia, PA 19112
- United States
Iroko Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 16-Dec-2020 | Completed | Out of Business | |||
| 4. Debt Refinancing | 15-Jun-2016 | Completed | Generating Revenue | |||
| 3. Debt - General | 21-Nov-2013 | Completed | Clinical Trials - Phase 3 | |||
| 2. IPO | 31-Jul-2013 | $101M | Cancelled | Clinical Trials - Phase 2 | ||
| 1. Early Stage VC | 06-Oct-2010 | Completed | Startup |
Iroko Pharmaceuticals Comparisons
Industry
Financing
Details
Iroko Pharmaceuticals Competitors (21)
One of Iroko Pharmaceuticals’s 21 competitors is IPI Legacy Liquidation, a Formerly VC-backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IPI Legacy Liquidation | Formerly VC-backed | Seattle, WA | ||||
| Assertio Holdings | Formerly VC-backed | Lake Forest, IL | ||||
| Alvogen Group | Formerly PE-Backed | Morristown, NJ | ||||
| Faraday Pharmaceuticals | Venture Capital-Backed | Seattle, WA | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria |
Iroko Pharmaceuticals Patents
Iroko Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2010059244-A2 | Method for reducing thrombocytopenia and thrombocytopenia-associated mortality | Inactive | 21-Nov-2008 | ||
| WO-2010059244-A3 | Method for reducing thrombocytopenia and thrombocytopenia-associated mortality | Inactive | 21-Nov-2008 |
Iroko Pharmaceuticals Signals
Iroko Pharmaceuticals Investments & Acquisitions (4)
Iroko Pharmaceuticals’s most recent deal was a Merger/Acquisition with iCeutica. The deal was made on 28-Apr-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| iCeutica | 28-Apr-2011 | Merger/Acquisition | Drug Discovery | ||
| Merck & Co. (Non-US Commercial Rights of Aggrastat) | 30-Jan-2008 | Corporate Asset Purchase | Buildings and Property | ||
| Eli Lilly Canada (Rights of Vancocin in Canada) | 11-Sep-2007 | Corporate Asset Purchase | Buildings and Property | ||
| Merck & Co. (2 Pharmaceutical Products in the United States) | 26-Mar-2007 | Corporate Asset Purchase | Buildings and Property |
Iroko Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Iroko International |
Iroko Pharmaceuticals FAQs
-
When was Iroko Pharmaceuticals founded?
Iroko Pharmaceuticals was founded in 2007.
-
Where is Iroko Pharmaceuticals headquartered?
Iroko Pharmaceuticals is headquartered in Philadelphia, PA.
-
What is the size of Iroko Pharmaceuticals?
Iroko Pharmaceuticals has 290 total employees.
-
What industry is Iroko Pharmaceuticals in?
Iroko Pharmaceuticals’s primary industry is Drug Delivery.
-
Is Iroko Pharmaceuticals a private or public company?
Iroko Pharmaceuticals is a Private company.
-
What is Iroko Pharmaceuticals’s current revenue?
The current revenue for Iroko Pharmaceuticals is .
-
How much funding has Iroko Pharmaceuticals raised over time?
Iroko Pharmaceuticals has raised $215M.
-
Who are Iroko Pharmaceuticals’s competitors?
IPI Legacy Liquidation, Assertio Holdings, Alvogen Group, Faraday Pharmaceuticals, and Pfizer (Vienna) are some of the 21 competitors of Iroko Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process